drug harms

Document library

Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review

17.10.2013
Hepatitis C virus (HCV) infections are highly prevalent amongst people who inject drugs (PWID). Further development of measures leading to higher uptake of treatment and adherence in PWID and appropriate adaptation of...
Document library

Hepatitis C among injecting drug users is two times higher in Stockholm, Sweden than in Rotterdam, the Netherlands

02.12.2013
This study assessed risk behavior and preventive measures for hepatitis C among injecting drug users in Rotterdam, the Netherlands and Stockholm, Sweden.
Document library

The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference

05.08.2013
The burden of disease due to chronic viral hepatitis constitutes a public health threat in many Balkan and Mediterranean countries and will require national commitments in the form of strategic plans, financial...
Document library

Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness

23.08.2013
Further studies are needed to assess the effectiveness and impact of scaling up comprehensive packages of harm reduction interventions to minimise HIV and HCV transmission among PWID.
Document library

Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study

12.09.2013
HIV prevalence in this study of blood-borne viruses among image and performance enhancing drugs (IPED) injectors, was similar to that among injectors of psychoactive drugs.
Document library

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

18.04.2013
The prevalence of chronic HBV and HCV infection varies widely between European countries. Cost-effectiveness analyses may need to take effect of antiviral treatment on preventing HBV and HCV transmission.
Document library

Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?

28.02.2013
Amongst injecting drug users (IDUs), HIV is transmitted sexually and parenterally, but HCV is transmitted primarily parenterally. We assess and model the antibody prevalence of HCV amongst HIV-infected IDUs.
Video thumbnail: hepatitis C treatment
Media library

Video: Hepatitis C treatment among injecting drug users

08.05.2013
Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today. In this analysis, the EMCDDA looks...
Video thumbnail: Aristoteles
Media library

Response to an HIV outbreak in people who inject drugs in Athens (ARISTOTLE programme)

17.11.2016
Angelos Hatzakis, MD, PhD is one of the winners of the 2016 EMCDDA scientific award. The prize, inaugurated in 2011 by the EMCDDA and its Scientific Committee, celebrates scientific writing and distinguishes...
Video thumbnail: NPS hospital emergencies
Media library

Interview: Responses to new psychoactive substances in hospital emergencies

16.06.2016
Information on health responses to the use of new psychoactive substances (NPS) is emerging but, in many cases, remains anecdotal.
Subscribe to drug harms
Top